These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Montesinos JJ; Flores-Figueroa E; Castillo-Medina S; Flores-Guzmán P; Hernández-Estévez E; Fajardo-Orduña G; Orozco S; Mayani H Cytotherapy; 2009; 11(2):163-76. PubMed ID: 19152152 [TBL] [Abstract][Full Text] [Related]
44. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Tondreau T; Meuleman N; Delforge A; Dejeneffe M; Leroy R; Massy M; Mortier C; Bron D; Lagneaux L Stem Cells; 2005 Sep; 23(8):1105-12. PubMed ID: 15955825 [TBL] [Abstract][Full Text] [Related]
45. Endothelial colony forming cells and mesenchymal stem cells are enriched at different gestational ages in human umbilical cord blood. Javed MJ; Mead LE; Prater D; Bessler WK; Foster D; Case J; Goebel WS; Yoder MC; Haneline LS; Ingram DA Pediatr Res; 2008 Jul; 64(1):68-73. PubMed ID: 18360305 [TBL] [Abstract][Full Text] [Related]
46. OCT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Seo KW; Lee SR; Bhandari DR; Roh KH; Park SB; So AY; Jung JW; Seo MS; Kang SK; Lee YS; Kang KS Biochem Biophys Res Commun; 2009 Jun; 384(1):120-5. PubMed ID: 19394308 [TBL] [Abstract][Full Text] [Related]
47. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Zhang YN; Lie PC; Wei X Cytotherapy; 2009; 11(5):548-58. PubMed ID: 19657806 [TBL] [Abstract][Full Text] [Related]
48. Adult lung side population cells have mesenchymal stem cell potential. Martin J; Helm K; Ruegg P; Varella-Garcia M; Burnham E; Majka S Cytotherapy; 2008; 10(2):140-51. PubMed ID: 18368593 [TBL] [Abstract][Full Text] [Related]
49. Hepatic differentiation of cord blood-derived multipotent progenitor cells (MPCs) in vitro. Moon YJ; Lee MW; Yoon HH; Yang MS; Jang IK; Lee JE; Kim HE; Eom YW; Park JS; Kim HC; Kim YJ; Lee KH Cell Biol Int; 2008 Oct; 32(10):1293-301. PubMed ID: 18703150 [TBL] [Abstract][Full Text] [Related]
50. Immunophenotype characterization of rat mesenchymal stromal cells. Harting M; Jimenez F; Pati S; Baumgartner J; Cox C Cytotherapy; 2008; 10(3):243-53. PubMed ID: 18418770 [TBL] [Abstract][Full Text] [Related]
51. Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells. Sakurai H; Okawa Y; Inami Y; Nishio N; Isobe K Stem Cells; 2008 Jul; 26(7):1865-73. PubMed ID: 18450822 [TBL] [Abstract][Full Text] [Related]
52. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138 [TBL] [Abstract][Full Text] [Related]
53. Phenotype and chondrogenic differentiation of mesenchymal cells from adipose tissue of different species. Martínez-Lorenzo MJ; Royo-Cañas M; Alegre-Aguarón E; Desportes P; Castiella T; García-Alvarez F; Larrad L J Orthop Res; 2009 Nov; 27(11):1499-507. PubMed ID: 19408284 [TBL] [Abstract][Full Text] [Related]
54. Regulation of human umbilical cord blood-derived multi-potent stem cells by autogenic osteoclast-based niche-like structure. Sun B; Jeong YH; Jung JW; Seo K; Lee YS; Kang KS Biochem Biophys Res Commun; 2007 May; 357(1):92-8. PubMed ID: 17408591 [TBL] [Abstract][Full Text] [Related]
55. In vitro hepatic differentiation of human umbilical cord blood and bone marrow cells. Jung YJ; Ryu KH; Cho KA; Woo SY; Seoh JY; Cho SJ; Joo SY; Yoo K; Ho-Seoung H Pediatr Hematol Oncol; 2008 Sep; 25(6):481-91. PubMed ID: 18728967 [TBL] [Abstract][Full Text] [Related]
56. In-vitro differentiation study on isolated human mesenchymal stem cells. Mok PL; Cheong SK; Leong CF Malays J Pathol; 2008 Jun; 30(1):11-9. PubMed ID: 19108406 [TBL] [Abstract][Full Text] [Related]
57. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use. Chung MJ; Park S; Son JY; Lee JY; Yun HH; Lee EJ; Lee EM; Cho GJ; Lee S; Park HS; Jeong KS Cell Cycle; 2019 Nov; 18(21):2954-2971. PubMed ID: 31505996 [TBL] [Abstract][Full Text] [Related]
58. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Kestendjieva S; Kyurkchiev D; Tsvetkova G; Mehandjiev T; Dimitrov A; Nikolov A; Kyurkchiev S Cell Biol Int; 2008 Jul; 32(7):724-32. PubMed ID: 18396423 [TBL] [Abstract][Full Text] [Related]
59. Establishment of a clonal human mesenchymal cell line that retains multilineage differentiation capacity from a spinal hamartoma. Doiguchi Y; Tsukazaki T; Tomonaga T; Nobuta M; Fujita S; Hayashi T; Nagai K; Matsumoto T; Shindo H; Yamaguchi A Cell Tissue Res; 2004 Sep; 317(3):237-46. PubMed ID: 15300494 [TBL] [Abstract][Full Text] [Related]
60. Calcification or dedifferentiation: requirement to lock mesenchymal stem cells in a desired differentiation stage. Dickhut A; Pelttari K; Janicki P; Wagner W; Eckstein V; Egermann M; Richter W J Cell Physiol; 2009 Apr; 219(1):219-26. PubMed ID: 19107842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]